China · 
Who invested in Genoimmune Therapeutics?
Genoimmune Therapeutics's investors include GF Xinde Investment Management.
China · Series A startup
Who invested in Genoimmune Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$18Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $18MMar 2019
- Investors
- 1
The rounds
- Mar 2019
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Genoimmune Therapeutics
How much has Genoimmune Therapeutics raised?
Genoimmune Therapeutics has raised $18M across 1 round since 2019.
When did Genoimmune Therapeutics last raise?
Genoimmune Therapeutics's most recent round was a Series A of $18M in Mar 2019.
What was Genoimmune Therapeutics's biggest round?
Its most recent round, $18M in Mar 2019, is also its largest on record.
Who backed Genoimmune Therapeutics first?
Genoimmune Therapeutics's first round on record, in Mar 2019, was backed by GF Xinde Investment Management.
What stage is Genoimmune Therapeutics at?
Genoimmune Therapeutics's latest named round is a Series A, in Mar 2019.
Where is Genoimmune Therapeutics based?
Genoimmune Therapeutics is based in China.
Companies like Genoimmune Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.